Altimmune to Announce Third Quarter 2021 Financial Results on November 10, 2021
04 November 2021 - 7:01AM
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical
company, today announced that it will report its third quarter 2021
financial results on Wednesday, November 10, 2021.
Altimmune management will host a conference call
for investors beginning at 8:30 am E.T. to discuss the third
quarter 2021 financial results and provide a business update.
Conference Call Information:
| Date: |
Wednesday,
November 10 |
| Time: |
8:30 am Eastern Time |
| Domestic Dial-in: |
(844) 615-6509 |
| International Dial-in: |
(918) 922-3148 |
| Conference ID: |
5783655 |
| Webcast: |
https://edge.media-server.com/mmc/p/zgrrmubx |
About AltimmuneAltimmune is a
clinical stage biopharmaceutical company focused on developing
treatments for obesity and liver diseases. Our pipeline includes
next generation peptide therapeutics for obesity, NASH (ALT-801),
and chronic hepatitis B (HepTcell™). For more information on
Altimmune, please visit www.altimmune.com.
Follow @Altimmune, Inc. on
LinkedInFollow @AltimmuneInc on
Twitter
Investor and Media Contact:Will BrownChief
Financial OfficerPhone: 240-654-1450wbrown@altimmune.com
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Apr 2023 to Apr 2024
